{"id":"cyclophosphamide-and-topotecan","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, thrombocytopenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Hemorrhagic cystitis (cyclophosphamide-related)"}]},"_chembl":{"chemblId":"CHEMBL1200796","moleculeType":"Small molecule","molecularWeight":"279.10"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Cyclophosphamide is a nitrogen mustard alkylating agent that cross-links DNA strands, preventing replication and transcription. Topotecan inhibits topoisomerase I, an enzyme required to relieve DNA tension during replication, leading to DNA breaks. The combination exploits complementary mechanisms to enhance cytotoxicity in rapidly dividing cancer cells.","oneSentence":"This combination uses cyclophosphamide as an alkylating agent to damage cancer cell DNA and topotecan as a topoisomerase I inhibitor to prevent DNA repair, working synergistically to kill cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:30:19.096Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pediatric solid tumors (Phase 2 investigational)"}]},"trialDetails":[{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":"Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":478},{"nctId":"NCT07437963","phase":"PHASE1, PHASE2","title":"Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-05-01","conditions":"Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma, Refractory Ganglioneuroblastoma","enrollment":76},{"nctId":"NCT02298348","phase":"PHASE1","title":"Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2015-10-08","conditions":"Neuroblastoma","enrollment":18},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT07194044","phase":"PHASE1","title":"Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-02","conditions":"Metastatic Ewing Sarcoma","enrollment":15},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT06647953","phase":"PHASE3","title":"Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-03-21","conditions":"Pleuropulmonary Blastoma","enrollment":110},{"nctId":"NCT04322318","phase":"PHASE2","title":"A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-10-19","conditions":"Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor","enrollment":256},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT06528496","phase":"PHASE2","title":"N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-07-22","conditions":"High-risk Neuroblastoma, Neuroblastoma, Childhood Neuroblastoma","enrollment":45},{"nctId":"NCT05421897","phase":"PHASE1","title":"Rapid Administration Pilot for Infusing Dinutuximab","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2022-11-29","conditions":"Neuroblastoma","enrollment":11},{"nctId":"NCT01175356","phase":"PHASE1","title":"Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-12-21","conditions":"Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma","enrollment":99},{"nctId":"NCT01231906","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2010-11-24","conditions":"Localized Extraskeletal Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor of Bone, Peripheral Primitive Neuroectodermal Tumor of Soft Tissues","enrollment":642},{"nctId":"NCT02813135","phase":"PHASE1, PHASE2","title":"European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2016-08-03","conditions":"Pediatric Cancer","enrollment":472},{"nctId":"NCT00602667","phase":"PHASE2","title":"Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-17","conditions":"Brain and Central Nervous System Tumors","enrollment":293},{"nctId":"NCT07321912","phase":"PHASE2","title":"Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-04-01","conditions":"Osteosarcoma, Ewing Sarcoma, Ewing Sarcoma Metastatic","enrollment":406},{"nctId":"NCT06861244","phase":"PHASE2","title":"Embryonal Tumor With Multilayered Rosettes","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-06","conditions":"Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos","enrollment":70},{"nctId":"NCT01757626","phase":"PHASE1, PHASE2","title":"Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-12","conditions":"Neuroblastoma","enrollment":186},{"nctId":"NCT05521984","phase":"PHASE1","title":"Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-04-03","conditions":"Pediatric Brain Tumor, Pediatric Solid Tumor","enrollment":20},{"nctId":"NCT01857934","phase":"PHASE2","title":"Therapy for Children With Advanced Stage Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-07-05","conditions":"Neuroblastoma","enrollment":153},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":"Ganglioneuroblastoma, High Risk Neuroblastoma","enrollment":42},{"nctId":"NCT03107988","phase":"PHASE1","title":"NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2017-09-05","conditions":"Neuroblastoma","enrollment":65},{"nctId":"NCT00186888","phase":"PHASE3","title":"Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2005-04-07","conditions":"Retinoblastoma, Retinal Neoplasm","enrollment":107},{"nctId":"NCT04947501","phase":"EARLY_PHASE1","title":"A Study of N9 Chemotherapy in Children With Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-06-22","conditions":"Neuroblastoma, Pediatric Cancer","enrollment":26},{"nctId":"NCT04106219","phase":"PHASE1","title":"A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2020-06-11","conditions":"Neuroblastoma","enrollment":71},{"nctId":"NCT02419495","phase":"PHASE1","title":"Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06-26","conditions":"Advanced Malignant Solid Neoplasm, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":221},{"nctId":"NCT02354547","phase":"PHASE1","title":"A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors","status":"SUSPENDED","sponsor":"SynerGene Therapeutics, Inc.","startDate":"2014-12","conditions":"Neoplasm","enrollment":18},{"nctId":"NCT06933394","phase":"PHASE2","title":"Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-05-01","conditions":"Neuroblastoma","enrollment":92},{"nctId":"NCT02030964","phase":"PHASE1","title":"N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2014-01-16","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT04701645","phase":"PHASE1","title":"Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-01","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":20},{"nctId":"NCT03709680","phase":"PHASE2","title":"Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2019-05-24","conditions":"Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor","enrollment":128},{"nctId":"NCT04029688","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2020-01-27","conditions":"Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma","enrollment":38},{"nctId":"NCT06669013","phase":"PHASE3","title":"Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas","status":"RECRUITING","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2021-05-20","conditions":"Bone Sarcoma, Embryonal Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma","enrollment":40},{"nctId":"NCT01798004","phase":"PHASE1","title":"Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-04-09","conditions":"Ganglioneuroblastoma, Stage 1 Neuroblastoma, Stage 2 Neuroblastoma","enrollment":150},{"nctId":"NCT02308527","phase":"PHASE2","title":"Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2013-07","conditions":"Neuroblastoma","enrollment":225},{"nctId":"NCT01783535","phase":"PHASE2","title":"Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-06-19","conditions":"Retinoblastoma","enrollment":174},{"nctId":"NCT01606878","phase":"PHASE1","title":"Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-04-29","conditions":"Childhood Solid Neoplasm, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Neuroblastoma","enrollment":46},{"nctId":"NCT06088030","phase":"PHASE2","title":"Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer","status":"RECRUITING","sponsor":"Yang Li","startDate":"2023-12-13","conditions":"Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations","enrollment":50},{"nctId":"NCT03600649","phase":"PHASE1","title":"Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas","status":"UNKNOWN","sponsor":"Salarius Pharmaceuticals, LLC","startDate":"2018-06-04","conditions":"Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue","enrollment":50},{"nctId":"NCT05266196","phase":"PHASE1, PHASE2","title":"A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)","status":"UNKNOWN","sponsor":"Salarius Pharmaceuticals, LLC","startDate":"2022-01-15","conditions":"Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor","enrollment":10},{"nctId":"NCT02665065","phase":"PHASE3","title":"Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actinium Pharmaceuticals","startDate":"2016-06","conditions":"Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute","enrollment":153},{"nctId":"NCT00005962","phase":"PHASE2","title":"Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2000-10-04","conditions":"Leukemia","enrollment":""},{"nctId":"NCT03236857","phase":"PHASE1","title":"A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies","status":"COMPLETED","sponsor":"AbbVie","startDate":"2017-11-08","conditions":"Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML)","enrollment":143},{"nctId":"NCT04661852","phase":"PHASE1","title":"Cabozantinib With Topotecan-Cyclophosphamide","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2020-12-23","conditions":"Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma","enrollment":12},{"nctId":"NCT05303727","phase":"PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2022-08","conditions":"Neuroblastoma","enrollment":64},{"nctId":"NCT00567567","phase":"PHASE3","title":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-11-05","conditions":"Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma","enrollment":665},{"nctId":"NCT02566993","phase":"PHASE3","title":"Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"PharmaMar","startDate":"2016-08-30","conditions":"Small-cell Lung Cancer","enrollment":613},{"nctId":"NCT00499616","phase":"PHASE3","title":"Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-10-08","conditions":"Neuroblastoma","enrollment":464},{"nctId":"NCT02390843","phase":"PHASE1","title":"Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-02","conditions":"Retinoblastoma, Clear Cell Sarcoma, Renal Cell Carcinoma","enrollment":13},{"nctId":"NCT02786719","phase":"NA","title":"High-Risk Neuroblastoma Chemotherapy Without G-CSF","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2016-06","conditions":"Neuroblastoma","enrollment":13},{"nctId":"NCT02684071","phase":"PHASE2","title":"Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors","status":"TERMINATED","sponsor":"Nicklaus Children's Hospital f/k/a Miami Children's Hospital","startDate":"2016-02","conditions":"Recurrent Childhood Medulloblastoma, Recurrent Childhood Ependymoma, Childhood Atypical Teratoid/Rhabdoid Tumor","enrollment":3},{"nctId":"NCT01492673","phase":"PHASE2","title":"Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2011-12","conditions":"Neuroblastoma, Sarcoma","enrollment":9},{"nctId":"NCT00652691","phase":"PHASE1","title":"Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"1998-08","conditions":"Ovarian Cancer, Peritoneal Cavity Cancer","enrollment":48},{"nctId":"NCT00003194","phase":"PHASE1","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"1997-07","conditions":"Unspecified Childhood Solid Tumor, Protocol Specific","enrollment":24},{"nctId":"NCT00877110","phase":"PHASE1","title":"Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-04-02","conditions":"Neuroblastoma, Bone Marrow, Sympathetic Nervous System","enrollment":71},{"nctId":"NCT01576692","phase":"PHASE1","title":"Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-04","conditions":"Neuroblastoma","enrollment":34},{"nctId":"NCT01039025","phase":"PHASE2","title":"TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-02-18","conditions":"Myeloma","enrollment":60},{"nctId":"NCT00004221","phase":"PHASE2","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer","status":"TERMINATED","sponsor":"Gynecologic Oncology Group","startDate":"1999-11","conditions":"Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma","enrollment":12},{"nctId":"NCT01670175","phase":"PHASE1","title":"Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-08","conditions":"Malignant Solid Tumor, Childhood Solid Tumor","enrollment":21},{"nctId":"NCT00808899","phase":"PHASE2","title":"Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2008-12","conditions":"Neuroblastoma","enrollment":4},{"nctId":"NCT03042429","phase":"PHASE3","title":"Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2007-01-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT00793351","phase":"PHASE2","title":"Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2008-09","conditions":"Neuroblastoma","enrollment":25},{"nctId":"NCT00526318","phase":"NA","title":"Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2007-01","conditions":"Neuroblastoma","enrollment":360},{"nctId":"NCT01795430","phase":"NA","title":"Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma","status":"WITHDRAWN","sponsor":"City of Hope Medical Center","startDate":"2013-07","conditions":"Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma","enrollment":""},{"nctId":"NCT00550784","phase":"PHASE1","title":"Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2001-01","conditions":"Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer","enrollment":8},{"nctId":"NCT00618813","phase":"NA","title":"Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-03","conditions":"Ewing Sarcoma of Bone, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor","enrollment":35},{"nctId":"NCT00516295","phase":"PHASE2","title":"Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-02","conditions":"Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor","enrollment":7},{"nctId":"NCT00070200","phase":"PHASE1","title":"Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-03","conditions":"Neuroblastoma","enrollment":31},{"nctId":"NCT00379457","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma","status":"UNKNOWN","sponsor":"European Paediatric Soft Tissue Sarcoma Study Group","startDate":"2006-06","conditions":"Sarcoma","enrollment":600},{"nctId":"NCT00410631","phase":"PHASE3","title":"Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2004-10","conditions":"Neuroblastoma","enrollment":642},{"nctId":"NCT00334867","phase":"PHASE3","title":"Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma","status":"WITHDRAWN","sponsor":"Children's Oncology Group","startDate":"2005-12","conditions":"Sarcoma","enrollment":""},{"nctId":"NCT00003198","phase":"PHASE1","title":"Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1997-11","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":""},{"nctId":"NCT00003958","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2002-09","conditions":"Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma","enrollment":702},{"nctId":"NCT00006373","phase":"PHASE2","title":"Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2000-02","conditions":"Lymphoma","enrollment":27},{"nctId":"NCT00004188","phase":"PHASE3","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-02","conditions":"Neuroblastoma","enrollment":495},{"nctId":"NCT00003944","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"1998-08","conditions":"Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer","enrollment":3},{"nctId":"NCT00003943","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"1998-09","conditions":"Carcinoma of Unknown Primary, Lung Cancer","enrollment":3},{"nctId":"NCT00004186","phase":"PHASE1, PHASE2","title":"Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"1996-12","conditions":"Lung Cancer","enrollment":55},{"nctId":"NCT00040872","phase":"PHASE2","title":"Multiple Therapies in Treating Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-06","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00002643","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1995-04","conditions":"Neutropenia, Sarcoma","enrollment":130},{"nctId":"NCT00006032","phase":"PHASE2","title":"Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2000-03","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00003211","phase":"PHASE2","title":"Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1996-10","conditions":"Brain and Central Nervous System Tumors","enrollment":94},{"nctId":"NCT00005612","phase":"PHASE1, PHASE2","title":"Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"1999-08","conditions":"Ovarian Cancer","enrollment":3},{"nctId":"NCT00502892","phase":"PHASE1","title":"Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-08","conditions":"Solid Tumors","enrollment":2},{"nctId":"NCT00004006","phase":"PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-11","conditions":"Retinoblastoma","enrollment":4},{"nctId":"NCT00186849","phase":"PHASE2","title":"Therapy for Children With Advanced Stage High Risk Neuroblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-10","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT00628732","phase":"PHASE2","title":"A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors","status":"COMPLETED","sponsor":"Children's Medical Center Dallas","startDate":"2005-01","conditions":"Solid Tumors","enrollment":36},{"nctId":"NCT00001335","phase":"PHASE2","title":"New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-04","conditions":"Ewing's Sarcoma, Neuroblastoma, Rhabdomyosarcoma","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cytoxan and Hycamptin"],"phase":"phase_2","status":"active","brandName":"Cyclophosphamide and Topotecan","genericName":"Cyclophosphamide and Topotecan","companyName":"Children's Medical Center Dallas","companyId":"children-s-medical-center-dallas","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination uses cyclophosphamide as an alkylating agent to damage cancer cell DNA and topotecan as a topoisomerase I inhibitor to prevent DNA repair, working synergistically to kill cancer cells. Used for Pediatric solid tumors (Phase 2 investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}